Evidence map

ReviewGlobal cardiology science & practice2017

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol.

Nabil G SeidahPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28971102